N-Boc-O-tosylserine methyl ester

Product Details

CAS No:56926-94-4

MF:C16H23NO7S

Appearance:white or off-white crystalline powder

Specification:98.5%

UN number:-

Package:1/5/10/25kgs/drum

Supply Capacity:Tons

Synonyms:N-Boc-3-(p-toluenesulfonyloxy)-L-serine Methyl ester, 98%;L-Serine,N-[(1,1-diMethylethoxy)carbonyl]-O-[(4-Methylphenyl)sulfonyl]-, Methyl ester;methyl N-(tert-butoxycarbonyl)-O-tosyl-L-serinate;(Tert-Butoxy)Carbonyl Ser(Tos)-OMe;BOC-L-SER(OTS)-OME;BOC-SER(TOS)-OCH3;BOC-SER(TOS)-OME;Boc-L-Ser(Tos)-OCH3,(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(tosyloxy)propanoate,"(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(tosyloxy)propanoate; 847-776-4; Boc-Ser(Tos)-OMe; 56926-94-4; MFCD01632224; methyl (2S)-3-(4-methylphenyl)sulfonyloxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate; N-Boc-O-tosyl-L-serine Methyl Ester; methyl N-(t-butoxycarbonyl)-O-tosyl-L-serinate; Boc-L-Ser(Tos)-OCH3; SCHEMBL9459961; DTXSID70426556; N-Boc-O-tosylserine methyl ester; VVBLIPVUGGNLGW-ZDUSSCGKSA-N; CS-M3183; AKOS015888380; FB72160; DS-14868; HY-79877; PD196133; SY030350; M03324; O10224; methyl (2S)-2-(tert-butoxycarbonylamino)-3-(p-tolylsulfonyloxy)propanoate; Methyl 3-(p-toluenesulfonyloxy)-2-(S)-(t-butoxycarbonylamino)propionate; (2S)-2-[N-(tert-Butoxycarbonyl)amino]-3-[[(4-methylphenyl)sulfonyl]oxy]propionate; (S)-2,6-Bis(tert-butyloxycarbonylamino)hexanoic acid; Di(N-Boc)-L-lysine; Di-tert-butoxycarbonyl-L-lysine",373.400,C16H23NO7S,

Product application:N-Boc-O-tosylserine methyl ester, 56926-94-4, Boc-Ser(OTs)-OMe, N-(tert-Butoxycarbonyl)-O-tosyl-L-serine methyl ester, chiral amino acid derivatives, peptide synthesis intermediates, pharmaceutical intermediates, N-Boc-L-Serine methyl ester tosylate, high purity chemical reagents, Suzhou Health Chemicals Co., Ltd. supplier, chemical building blocks.

 

N-Boc-O-tosylserine methyl ester is a protected chiral serine derivative with a tosylated hydroxyl group, which acts as an excellent leaving group. It is widely utilized as a key intermediate in peptide synthesis, the modification of amino acid side chains (such as sulfur or nitrogen incorporation), and the development of bioactive molecules in pharmaceutical R&D.